Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> MutationBella Kaufman, Susan M. Domchek, Gillian Mitchell et al.|Journal of Clinical Oncology|2014Cited by 1.7k
Efficacy and safety of olaparib monotherapy in germline BRCA1 / 2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapySusan M. Domchek, Bella Kaufman, Carol Aghajanian et al.|Gynecologic Oncology|2015Cited by 300
ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of originRonen Sadeh, Nir Friedman, Israa Sharkia et al.|Nature Biotechnology|2021Cited by 169